PATENT CLAIM ANALYSIS

Application Number: 16202008
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-08
Patent Classification: ["604", "506000"]

Abstract:
Plantar Heel Pain Syndrome can be of one or more etiologies and symptoms which refutes the mistaken tendency to categorize all plantar heel pain singularly as either plantar fasciitis or fasciosis. Recognizing that there is likely an interplay of inflammatory, degenerative and neuropathic etiologic conditions of this often-difficult malady to treat, a novel injection paradigm of botulinum toxin is explored in the treatment of 4 distinct presentations of Plantar Heel Pain Syndrome with promising results.

Claim (Index 3):
The method of  claim 1 , wherein the botulinum toxin is injected using a needle.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 98.0
- Lexical Diversity: 1.27419
- Patent Class: 604.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11504198', '14791389', '11056382', '16178334', '15917492']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8035192929788444
- 35 USC 102 Novelty (BERT): 0.4749354991891625
- Combined Prediction Score: 0.7706609135998763
- Mean Citation Score: 223.106332
- Max Citation Score: 231.65848
- Similarity Product: 194.1397892567157

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test